When liver cells store too much fat, the liver becomes inflamed and damaged. This is commonly the result of years of alcohol abuse, but a growing number of people are being diagnosed with a similar issue without the heavy drinking.
The term for this condition is nonalcoholic fatty liver disease, and it affects an estimated 80 to 100 million people. Nonalcoholic steatohepatitis, or NASH, is the most severe form of the disease. Once the condition reaches this stage, it can lead to scarring, fibrosis, liver cancer, cirrhosis, or liver failure.
NASH is linked to overweight or obesity, insulin resistance, high blood sugar, and high levels of fats in the blood. While some people experience fatigue or pain or swelling in the abdomen, most people do not display any symptoms, making NASH difficult to diagnose.
NASH Study Qualifications
Advances in drug therapy are key to treating this disease at its early stages and preventing further liver damage. If you have a suspected diagnosis of NASH, you may be interested in an upcoming study.
Participants must meet the following qualifications:
- At least 18 years old
- A suspected diagnosis of NASH
- Cannot have known non-NASH liver diseases including:
- Alcoholic liver disease
- Autoimmune diseases
- Active Hepatitis C
Ready to Volunteer?
Volunteer today to see if you qualify for our NASH clinical research study, Qualified volunteers may be compensated for time and travel.